No Data
No Data
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
BofA Securities Maintains Viatris(VTRS.US) With Sell Rating
BofA Securities analyst Jason Gerberry maintains $Viatris(VTRS.US)$ with a sell rating.According to TipRanks data, the analyst has a success rate of 44.4% and a total average return of -0.6% over
Express News | Viatris Inc : BofA Global Research Cuts Price Objective to $11 From $12
Express News | Reported Thursday, Calliditas Therapeutics And Viatris Initiate Phase III Clinical Trial Of Nefecon For IgA Nephropathy In Japan
Express News | Viatris Brings to Completion All Previously Announced Divestitures With the Closing of Its Over-the-Counter Business Divestiture
Viatris Has Closed the Divestiture of Its Over-the-Counter Business to Cooper Consumer Health >VTRS
Viatris Has Closed the Divestiture of Its Over-the-Counter Business to Cooper Consumer Health >VTRS
No Data
Ape Power :
KEN GRIFFIN COMMITTED FRAUD LIVE ON AIR!
- AMC Stock Short Squeeze Update